Abstract
Currently,
bupivacaine liposome injectable suspension (Exparel™, PACIRA BIOSCIENCES, INC., Tampa, Florida, USA) has
approval by the Food and Drug Administration for the management of
postoperative pain in various surgical patients. In this case report, we
suggest the addition of introducing its use in surgical procedures involving
the neck, specifically, patients undergoing carotid endarterectomy. The
infiltration of liposomal bupivacaine into the superficial cervical plexus has
proved to provide adequate pain relief for approximately 72 hours
postoperatively discarding the use of other analgesics. Despite the findings,
this calls for a larger study comparing the efficacy of different postoperative
pain management protocols.
Keywords: Liposomal Bupivacaine, Regional Anesthesia, Endarterectomy,
Pain Management.